Press Releases

All Releases
Jan 07, 2016
AngioDynamics Reports Fiscal 2016 Second Quarter Results
Net sales of $89.2 million GAAP loss of $0.01 per share; Non-GAAP adjusted EPS of $0.14 Operating cash generation of $9.6 million ALBANY, N.Y. , Jan. 07, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access,
Dec 28, 2015
AngioDynamics to Report Fiscal 2016 Second Quarter Financial Results
ALBANY, N.Y. , Dec. 28, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2016 second
Nov 17, 2015
AngioDynamics Announces Resolution of FDA Warning Letter
ALBANY, N.Y. , Nov. 17, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announces that it has received a letter from the United Stated Food and Drug
Oct 08, 2015
AngioDynamics Reports Fiscal 2016 First Quarter Results
Net sales of $83.7 million GAAP loss of $0.02 per share; Non-GAAP adjusted EPS of $0.11 Operating cash generation of $4.7 million Management provides Q2 outlook and reiterates FY2016 guidance ALBANY, N.Y. , Oct. 08, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of
Oct 01, 2015
AngioDynamics to Report Fiscal 2016 First Quarter Financial Results
ALBANY, N.Y. , Oct. 1, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2016 first
Aug 13, 2015
Research Data Published in Annals of Surgery Concludes Irreversible Electroporation Utilizing NanoKnife Results in Substantially Prolonged Survival for Patients With Locally Advanced Pancreatic Cancer Compared With Historical Controls
ALBANY, N.Y. , Aug. 13, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today the publication of clinical data from STAR (Soft Tissue Ablation
Displaying 81 - 100 of 644